Lynn A. Tetrault, Director at RHYTHM PHARMACEUTICALS, INC. (RYTM), sold 4,300 shares at $50.01 ($215K) on 2024-08-26, disclosed to the SEC on 2024-08-28.
Scheduled sale ($215k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| NEO | SELL | 2026-06-11 | $60K | — | Filing → |
| NEO | BUY | 2025-05-09 | $114K | — | Filing → |
| RYTM | SELL | 2024-09-11 | $2.0M | — | Filing → |